Science & Enterprise subscription

Follow us on Twitter

  • Our #podcast is now live ... NPC Members Display Photos At Annual Club Exhibit https://t.co/EsClVw9ZNc @pressclubdc #NPCPhotoEx
    about 1 day ago
  • More Democrats say they're in favor of increased federal spending on scientific research than Republicans, a gap th… https://t.co/SQBna2FykD
    about 1 day ago
  • New post on Science and Enterprise: Infographic – Partisan Split Remains on Research Spending https://t.co/FabPa5ufSb #Science #Business
    about 1 day ago
  • The first participant in a clinical trial received an experimental minimally-invasive brain implant to record brain… https://t.co/nPUNY6S2a5
    about 2 days ago
  • New post on Science and Enterprise: Trial Underway Testing Brain-Computer Implant https://t.co/olPDnbtfnW #Science #Business
    about 2 days ago

Please share Science & Enterprise

Stanford, Berkeley, MIT Top Undergrad Start-Up Ranking

Shop open sign

Stanford University, University of California in Berkeley, and Massachusetts Institute of Technology lead the undergraduate programs producing founders of start-up companies in 2019. . . . → Read More: Stanford, Berkeley, MIT Top Undergrad Start-Up Ranking

Response by Patients Shown to Precision Lung Cancer Drug

Lung cancer illustration

Results of a clinical trial show a treatment targeting specific genetic aberrations produces a therapeutic response in most patients with lung cancer from that condition. . . . → Read More: Response by Patients Shown to Precision Lung Cancer Drug

Sumitomo Dainippon, Biotechs in $3B Acquisition Deal

Laptops on a table

Japanese pharmaceutical company Sumitomo Dainippon agreed to acquire five biotechnology companies and gain an equity stake in the Roivant Sciences group. . . . → Read More: Sumitomo Dainippon, Biotechs in $3B Acquisition Deal

Gates Investing in HIV, Tuberculosis Immunotherapies

T-cell infected by HIV

The Bill and Melinda Gates Foundation is taking an equity stake in a biotechnology company developing immunotherapies from messenger RNA. . . . → Read More: Gates Investing in HIV, Tuberculosis Immunotherapies

Urine Test Shows Promise for Cancer Screening

Mouse urine samples

Biomedical engineers and materials scientists developed a simple urine test that in samples from lab mice show they can screen for colon cancer. . . . → Read More: Urine Test Shows Promise for Cancer Screening

Carb-X Funds Drug-Resistant Bacterial Vaccine

Klebsiella pneumoniae

A company developing vaccines with synthetic biology is receiving a grant for a vaccine to prevent infections from drug-resistant Klebsiella pneumoniae bacteria. . . . → Read More: Carb-X Funds Drug-Resistant Bacterial Vaccine

Optic Nerve Stimulation Developed as Visual Prosthetic

OpticSeline array

Engineers in Europe developed an electronic device that connects to and stimulates the optic nerve, producing simple visual patterns in lab animals. . . . → Read More: Optic Nerve Stimulation Developed as Visual Prosthetic

FDA Okays Celiac Disease Engineered Microbe Trial

fresh bread

A company making synthetic biological therapies received authorization to begin clinical trials in the U.S. for an engineered microbe to treat celiac disease. . . . → Read More: FDA Okays Celiac Disease Engineered Microbe Trial

Aging Therapy Network Adds $100M to Venture Round

Hands on lap

An enterprise supporting a group of companies developing new drugs to address the aging process raised another $100 million in its second venture funding round. . . . → Read More: Aging Therapy Network Adds $100M to Venture Round

MD Anderson, Drug Maker Partner on Lung, GI Cancers

Cancer magnified

MD Anderson Cancer Center and drug maker Boehringer Ingelheim agreed to jointly develop new treatments for lung and gastrointestinal cancers. . . . → Read More: MD Anderson, Drug Maker Partner on Lung, GI Cancers